50
Participants
Start Date
October 24, 2023
Primary Completion Date
July 6, 2026
Study Completion Date
July 6, 2026
Apremilast
Oral tablet
RECRUITING
OptiSkin Medical, New York
RECRUITING
State University of New York, Downstate Medical Center, Manhasset
RECRUITING
Empire Dermatology, East Syracuse
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Pediatric Skin Research LLC, Coral Gables
RECRUITING
Ciocca Dermatology, Miami
RECRUITING
University of South Florida, Tampa
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RECRUITING
Southern Indiana Clinical Trials, New Albany
RECRUITING
Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion), Detroit
RECRUITING
Great Lakes Research Group Inc- Sheffield, Bay City
RECRUITING
Boeson Research, Missoula
RECRUITING
Endeavor Health Clinical Trials Center, Skokie
RECRUITING
Dermatology and Skin Cancer Center of Lees Summit, Lee's Summit
RECRUITING
Johnson Dermatology Clinic, Fort Smith
TERMINATED
Hightower Clinical LLC, Oklahoma City
TERMINATED
Dermatology Research Center of Oklahoma, PLLC, Tulsa
RECRUITING
Studies in Dermatology LLC, Cypress
RECRUITING
Stride Clinical Research LLC, Sugar Land
TERMINATED
Austin Institute for Clinical Research, Pflugerville
TERMINATED
Affiliated Dermatology, Scottsdale
RECRUITING
Clear Dermatology, Scottsdale
TERMINATED
Clinical Science Institute, Santa Monica
RECRUITING
California Dermatology Institute, Thousand Oaks
RECRUITING
MedDerm Associates, San Diego
RECRUITING
Avance Clinical Trials, Laguna Niguel
RECRUITING
University of California Irvine, Orange
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
Frontier Derm Partners, Mill Creek
Lead Sponsor
Amgen
INDUSTRY